Search
Regulatory affairs & scientific relations
EHA’s regulatory work: European Medicines AgencyMost of EHA’s regulatory work entails collaboration with the European Medicines Agency (EMA).
Read moreSubstances of Human Origin (SoHO) legislation
EHA’s involvementEHA has been involved in both the evaluation and subsequent revision of the EU legislation on human blood and blood components. The evaluation of these rules, which dated back to 2002, began in 2016.
Read moreEHA Kick-off Grants
The call for applications is closed. The EHA Kick-off Grant is a one-year grant intended to support basic and translational early career researchers in hematology.
Read moreChairs and Members
Chair (2017-present)Oliver A. Cornely—University Hospital Cologne, Cologne (Germany)
Co-chair (2023-present)Livio Pagano—Fondazione Policlinico A.
Support opportunities
View the EHA Ranking for 2025
EHA thrives on the support of the biomedical industry and the medical profession. The variety of opportunities available for industry range from educational activities to the EHA Congress.
Registration & accommodation
Register here
Individual registrationIn-person registration fee includes:
Access to the scientific and educational sessions of the meeting
Networking opportunities to speak with the faculty during breaks and the welcome reception
Coffee/tea breaks and lunches on April 25 and 26
Access to the poster sessions and…
Addressing immunoglobulin shortages: EHA and EBA’s strategic recommendations at the EMA
In recent years, shortages of immunoglobulins (Ig) have become a growing concern in the European Union (EU). Since 2018, the European Medicines Agency (EMA)—the EU agency that evaluates and supervises medicines—has received an increasing number of shortage reports.
Read morePolicy on double awarding
We want to support as many young investigators and clinicians as possible in their career development. For this reason, we do not allow ‘double awarding.
Read more